slotkoers
Ho Chi Minh S.E.
00:00:00 10-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
66.500
VND
|
-0,45%
|
|
+2,15%
|
+17,49%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
2.370.593
|
3.753.609
|
5.187.048
|
4.013.628
|
3.962.167
|
4.655.309
|
-
|
-
|
Bedrijfswaarde
1 |
2.370.593
|
3.753.609
|
5.187.048
|
4.013.628
|
3.962.167
|
4.712.309
|
4.655.309
|
4.655.309
|
K/w-verhouding
|
-
|
20,3
x
|
29,9
x
|
17,2
x
|
15,6
x
|
13,7
x
|
-
|
-
|
Dividendrendement
|
2,08%
|
2,66%
|
1,93%
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
1,69
x
|
2,74
x
|
4,1
x
|
2,44
x
|
1,99
x
|
2,13
x
|
-
|
-
|
Bedrijfswaarde/omzet
|
1,69
x
|
2,74
x
|
4,1
x
|
2,44
x
|
1,99
x
|
2,15
x
|
-
|
-
|
Bedrijfswaarde/EBITDA
|
9.583.362
x
|
12.155.380
x
|
17.332.265
x
|
-
|
8.669.024
x
|
-
|
-
|
-
|
Bedrijfswaarde/FCF
|
-
|
-
|
-
|
14,4
x
|
-
|
18,7
x
|
14,9
x
|
13,5
x
|
FCF Yield
|
-
|
-
|
-
|
6,96%
|
-
|
5,35%
|
6,7%
|
7,39%
|
Price to Book
|
1,52
x
|
2,17
x
|
2,89
x
|
2,11
x
|
1,9
x
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
67.414
|
70.005
|
70.005
|
70.005
|
70.003
|
70.005
|
-
|
-
|
Referentieprijs
2 |
35.165
|
53.619
|
74.095
|
57.333
|
56.600
|
66.500
|
66.500
|
66.500
|
Datum van publicatie
|
20-01-20
|
19-01-21
|
20-01-22
|
17-01-23
|
19-01-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
1.402.454
|
1.369.422
|
1.266.597
|
1.643.707
|
1.994.037
|
2.190.000
|
-
|
-
|
EBITDA
|
247.366
|
308.802
|
299.271
|
-
|
457.049
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
184.427
|
252.540
|
234.475
|
300.992
|
374.407
|
449.000
|
497.000
|
546.000
|
Operationele Marge
|
13,15%
|
18,44%
|
18,51%
|
18,31%
|
18,78%
|
20,5%
|
-
|
-
|
Resultaat voor belastingen (EBT)
1 |
-
|
255.441
|
238.859
|
301.763
|
377.273
|
426.000
|
-
|
-
|
Nettowinst (verlies)
1 |
-
|
209.697
|
189.095
|
233.964
|
299.556
|
339.500
|
-
|
-
|
Nettomarge
|
-
|
15,31%
|
14,93%
|
14,23%
|
15,02%
|
15,5%
|
-
|
-
|
WPA
2 |
-
|
2.641
|
2.476
|
3.329
|
3.637
|
4.863
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
279.250
|
-
|
252.000
|
312.000
|
344.000
|
FCF-marge
|
-
|
-
|
-
|
16,99%
|
-
|
11,51%
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
119,36%
|
-
|
74,23%
|
-
|
-
|
Dividend per aandeel
|
732,6
|
1.429
|
1.429
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
20-01-20
|
19-01-21
|
20-01-22
|
17-01-23
|
19-01-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2023 Q1
|
2023 Q2
|
---|
Omzet
1 |
479.272
|
439.691
|
EBITDA
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-
|
99.157
|
Operationele Marge
|
-
|
22,55%
|
Resultaat voor belastingen (EBT)
1 |
-
|
100.003
|
Nettowinst (verlies)
1 |
-
|
79.675
|
Nettomarge
|
-
|
18,12%
|
WPA
|
978,1
|
-
|
Dividend per aandeel
|
-
|
-
|
Datum van publicatie
|
18-04-23
|
18-07-23
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
57.000
|
-
|
-
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
279.250
|
-
|
252.000
|
312.000
|
344.000
|
ROE (netto-inkomsten/eigen vermogen)
|
10,6%
|
12,8%
|
9,32%
|
12,6%
|
15,1%
|
15,3%
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
8,97%
|
10,6%
|
8,61%
|
10,2%
|
12,8%
|
13,9%
|
-
|
-
|
Totale activa
1 |
-
|
1.971.818
|
2.195.579
|
2.291.096
|
2.334.809
|
2.442.446
|
-
|
-
|
Nettoactief per aandeel
|
23.124
|
24.719
|
25.633
|
27.210
|
29.778
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
133.036
|
89.685
|
52.857
|
99.353
|
-
|
72.000
|
79.000
|
87.000
|
Capex/omzet
|
9,49%
|
6,55%
|
4,17%
|
6,04%
|
-
|
3,29%
|
-
|
-
|
Datum van publicatie
|
20-01-20
|
19-01-21
|
20-01-22
|
17-01-23
|
19-01-24
|
-
|
-
|
-
|
Laatste slotkoers
66.500
VND Gemiddelde koersdoel
77.033
VND Spread / Gemiddelde doel +15,84% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +17,49% | 183 mln. | | +30,38% | 684 mld. | | +26,51% | 568 mld. | | -4,36% | 361 mld. | | +19,30% | 329 mld. | | +3,73% | 284 mld. | | +16,70% | 240 mld. | | +8,78% | 208 mld. | | -7,93% | 200 mld. | | +7,68% | 166 mld. |
Farmaceutische producten - Andere
|